AIM ImmunoTech converts $400K debt to 1.75M shares at $0.228 per share

AIM ImmunoTech Inc.

Converted $400,000 of Nov 18, 2025 promissory note into 1,749,434 shares at avg $0.228/share via two exchange agreements.
Shares issued to Streeterville Capital under Section 3(a)(9) exemption; no cash consideration; reduces outstanding note balance.
Stockholders approved conversion at July 15, 2026 special meeting per NYSE American Company Guide Sections 713(a)/(b).
Original note principal $3,301,250; remaining balance outstanding after conversion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.